DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Boston Convention and Exhibition Center

2013年6月23日 (日) 午前 8:30 - 2013年6月27日 (木) 午後 12:45

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Quality Risk Management: An Old Hat?

Session Chair(s)

Beat  Widler, PHD

Beat Widler, PHD

Co-Founder and Vice President, ACRES; Managing Director

Widler & Schiemann AG, Switzerland

A risk-based approach to quality management in clinical trials is the obvious solution. However, many sponsors of clinical trials have attempted it and failed. This session will show the essentials and examples of a successful implementation.

Learning Objective : Discuss how to plan for and make a risk-based approach to quality management work in their environment; Describe what needs to be considered when implementing a risk-based quality management approach; Identify the challenges that need to be overcome for successful implementation.

Speaker(s)

Beat  Widler, PHD

QRM: Connecting the Operational Dots

Beat Widler, PHD

Widler & Schiemann AG, Switzerland

Co-Founder and Vice President, ACRES; Managing Director

Brian J. Nugent, BSN, RN

QRM: Tipping the Scales Towards Success – The Change Management Story

Brian J. Nugent, BSN, RN

Gilead Sciences, Inc., United States

Associate Director, Clinical Operations

Linda B Sullivan, MBA

Key Quality Indicators (KQIs): What are They? How Are They Being Used in Risk-based Monitoring Approaches?

Linda B Sullivan, MBA

Tufts Center For the Study of Drug Development, United States

Senior Fellow

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。